Kleefstra syndrome and epilepsy
https://doi.org/10.17650/2073-8803-2019-14-4-32-37
Abstract
Kleefstra syndrome is a rare autosomal dominant genetic disorder caused by haploinsufficiency of the EHMT1 (Euchromatic Histone MethylTransferase 1). Patients with Kleefstra syndrome have following most common symptoms: moderate or severe intellectual deficiency, absence of speech, significant diffuse muscular hypotonia, micro-brachycephaly, congenital defects of heart, kidneys, genitourinary tract and recognizable dysmorphic features of face. The article presents 2 similar clinical cases of Kleefstra syndrome in combination with epilepsy. Both patients, along with a typical clinical picture of the underlying disease, have serial epileptic spasms with an onset after first year of life, modified hypsarrhythmia with tendency to synchronization on the electroencephalogram, pharmacoresistant epilepsy. This indicates that Kleefstra syndrome can include epilepsy as one of symptoms of the disease.
About the Authors
R. G. Gamirova
Kazan State Medical Academy, branch of the Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia; Kazan Federal University
Russian Federation
11 Mushtari St., Kazan 420012, Russia; 18 Kremlevskaya St., Kazan 420000, Russia
Russian Federation
11 Mushtari St., Kazan 420012, Russia; 18 Kremlevskaya St., Kazan 420000, Russia
N. G. Lyukshina
Medical Center "MIDEAL"
Russian Federation
43 Leningradskaya St., Togliatti 445020, Russia
Russian Federation
43 Leningradskaya St., Togliatti 445020, Russia
R. R. Gamirova
Kazan Federal University
Russian Federation
18 Kremlevskaya St., Kazan 420000, Russia
Russian Federation
18 Kremlevskaya St., Kazan 420000, Russia
M. E. Farnosova
Children's City Hospital No. 8
Russian Federation
11 Bari Galeeva St., Kazan 420061, Russia
Russian Federation
11 Bari Galeeva St., Kazan 420061, Russia
References
1. Farnosova M.E., Gamirova R.G. Comparative analysis of therapy outcomes in patients with West syndrome receiving tetraсosactidе and other antiepileptic drugs. Russkiy zhurnal detskoy nevrologii = Russian Journal of Child Neurology 2017;12(3):44–50. (In Russ.) DOI: 10.17650/2073-8803-2017-12-3-44-50.
2. Benevento M., Iacono G., Selten M. et al. Histone methylation by the Kleefstra syndrome protein EHMT1 mediates homeostatic synaptic scaling. Neuron 2016;91(2):341–55. DOI: 10.1016/j.neuron.2016.06.003.
3. Blackburn P.R., Tischer A., Zimmermann M.T. et al. A novel Kleefstra syndrome associated variant that affects the conserved tplx motif within the ankyrin repeat of EHMT1 leads to abnormal protein folding. J Biol Chem 2017;292:3866–76. DOI: 10.1074/jbc.M116.770545.
4. Blackburn P.R., Williams M., Cousin M.A. et al. A novel de novo frameshift deletion in EHMT 1 in a patient with Kleefstra syndrome results in decreased H3K9 dimethylation. Mol Genet Genomic Med 2017;5(2):141–6. DOI: 10.1002/mgg3.268.
5. Gamirova R.G., Shaimardanova R.M., Ziganshina L.E. Pharmacoepidemiology of antiepileptic drugs in children: Comparative analysis of efficacy and safety. Int J Risk Saf Med 2012;24(3):179–85. DOI: 10.3233/JRS-2012-0565.
6. Hrachovy R.A., Frost Jr.J.D., Kellaway P. Hypsarrhythmia: variations on the theme. Epilepsia 1984;25:317–25.
7. Kleefstra T., Brunner H.G., Amiel J. et al. Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. Am J Hum Genet 2006;79(2):370–7. DOI: 10.1086/505693.
8. Kleefstra T., Kramer J.M., Neveling K. et al. Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability. Am J Hum Genet 2012;91(1):73–82. DOI: 10.1016/j.ajhg.2012.05.003.
9. Kleefstra T., Nillesen W.M., Yntema H.G. Kleefstra syndrome. Eds.: Pagon R.A., Bird T.D., Dolan C.R., Stephens K. GeneReviews. Last update 2015. University of Washington, Seattle, 1993–2018.
10. Koemans T.S., Kleefstra T., Chubak M.C. et al. Functional convergence of histone methyltransferases EHMT1 and KMT2C involved in intellectual disability and autism spectrum disorder. PLoS Genet 2017;13(10):e1006864. DOI: 10.1371/journal.pgen.1006864.
11. Nagy J., Kobolak J., Berzsenyi S. et al. Altered neurite morphology and cholinergic function of induced pluripotent stem cell-derived neurons from a patient with Kleefstra syndrome and autism. Translational Psychiatry 2017;7(7):e1179–89. DOI: 10.1038/tp.2017.144.
12. Noruzinia M., Ahmadvand M., Bashti O. et al. Kleefstra syndrome: the first case report from Iran. Acta Medica Iranica 2017;55(10):650–4.
13. Vermeulen K., de Boer A., Janzing J.G. et al. Adaptive and maladaptive functioning in Kleefstra syndrome compared to other rare genetic disorders with intellectual disabilities. Am J Med Genet Part A 2017;173(7):1821–30. DOI: 10.1002/ajmg.a.38280.
14. Willemsen M.H., Vulto-van Silfhout A.T., Nillesen W.M. et al. Update on Kleefstra syndrome. Mol Syndromol 2011;2(3–5): 202–12. DOI: 10.1159/000335648.
15. Willemsen M.H., Beunders G., Callaghan M. et al. Familial Kleefstra syndrome due to maternal somatic mosaicism for interstitial 9q34. 3 microdeletions. Clin Genet 2011;80(1):31–8. DOI: 10.1111/j.1399-0004.2010.01607.x.
Review
For citations:
Gamirova R.G., Lyukshina N.G., Gamirova R.R., Farnosova M.E. Kleefstra syndrome and epilepsy. Russian Journal of Child Neurology. 2019;14(4):32-37. (In Russ.) https://doi.org/10.17650/2073-8803-2019-14-4-32-37
Views:
7995
Email this article 